- Home
- PMEC vs LTRN Comparison
PMEC vs LTRN Comparison
Compare PMEC & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMEC
- LTRN
- Stock Information
- Founded
- PMEC 1984
- LTRN 2013
- Country
- PMEC Singapore
- LTRN United States
- Employees
- PMEC N/A
- LTRN N/A
- Industry
- PMEC
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- PMEC
- LTRN Health Care
- Exchange
- PMEC Nasdaq
- LTRN Nasdaq
- Market Cap
- PMEC 56.9M
- LTRN 49.9M
- IPO Year
- PMEC 2023
- LTRN 2020
- Fundamental
- Price
- PMEC $1.88
- LTRN $3.90
- Analyst Decision
- PMEC
- LTRN Strong Buy
- Analyst Count
- PMEC 0
- LTRN 1
- Target Price
- PMEC N/A
- LTRN $25.00
- AVG Volume (30 Days)
- PMEC 126.7K
- LTRN 164.4K
- Earning Date
- PMEC 01-01-0001
- LTRN 11-14-2025
- Dividend Yield
- PMEC N/A
- LTRN N/A
- EPS Growth
- PMEC N/A
- LTRN N/A
- EPS
- PMEC N/A
- LTRN N/A
- Revenue
- PMEC $74,349,000.00
- LTRN N/A
- Revenue This Year
- PMEC N/A
- LTRN N/A
- Revenue Next Year
- PMEC N/A
- LTRN N/A
- P/E Ratio
- PMEC N/A
- LTRN N/A
- Revenue Growth
- PMEC 2.52
- LTRN N/A
- 52 Week Low
- PMEC $0.54
- LTRN $2.55
- 52 Week High
- PMEC $2.44
- LTRN $6.12
- Technical
- Relative Strength Index (RSI)
- PMEC 49.65
- LTRN 42.88
- Support Level
- PMEC $1.67
- LTRN $3.80
- Resistance Level
- PMEC $2.30
- LTRN $4.28
- Average True Range (ATR)
- PMEC 0.21
- LTRN 0.30
- MACD
- PMEC -0.02
- LTRN -0.04
- Stochastic Oscillator
- PMEC 35.00
- LTRN 14.29
About PMEC Primech Holdings Ltd.
Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.